-
Estimating the Economic Burden of DLBCL: Developing and Testing a Cost of Disease Model
Sep 9, 2025, 16:22 PM -
Readying for the Second Wave: What, When, and How Must Orphan Medicine Manufacturers Prepare for EU HTAR?
Sep 9, 2025, 16:22 PM -
Increased Trends of Self-Optimized Submissions to NICE
Sep 9, 2025, 16:22 PM -
Correlation of Intermediate Clinical Endpoints (ICES) For Overall Survival (OS) In Localized or Locally Advanced Prostate Cancer (LPC/LAPC): Analysis of Individual Real-World Data (RWD)
Sep 9, 2025, 16:22 PM -
Understanding the Impact of Equality and Equity Considerations on NICE Highly Specialized Technology (HST) Decision Making
Sep 9, 2025, 16:22 PM -
Real-World Insights Into Prostate Cancer Management Using Electronic Health Record-Derived Data From the UK
Sep 9, 2025, 16:22 PM -
Impact of Maternal Vaccination Strategy on RSV-Related Hospital Burden Among Infants Aged Less Than One Year in France: A Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Sex Differences in Patients With Chronic Hand Eczema (CHE): Disease Manifestations and Quality of Life (QoL) Results From a Cross-Sectional Multinational Study
Sep 9, 2025, 16:22 PM -
Assessing the Impact of Technology-Powered, Pharmacy- and Nursing-Supported Direct Oral Anticoagulant Management
Sep 9, 2025, 16:22 PM -
Caregiver QALYs Deserve Better: Why It's Time for a Methodological Rethink
Sep 9, 2025, 16:22 PM -
Role of Technical Engagement in NICE Process Under Proportionate Approach to Technology Appraisals
Sep 9, 2025, 16:22 PM -
Personalized Treatment Optimization Using Reinforcement Learning on Real-World Data (RWD)
Sep 9, 2025, 16:22 PM -
AI Time and Motion - Analysis of the Accuracy and Efficiency of AI for HTA-Standard SLRs
Sep 9, 2025, 16:22 PM -
Strategies for More Cost-Effective HrHPV Screening: A Simulation Study of Pooled Testing Based on Real-World Data in Low- and Middle-Income Countries
Sep 9, 2025, 16:22 PM -
Demonstrating the Importance of Modeling Rapid Cancer Progression in Screening Evaluations
Sep 9, 2025, 16:22 PM -
Worth Their Weight? Cost-Effectiveness and Access Decisions for GLP-1 and GIP/GLP-1 Therapies
Sep 9, 2025, 16:22 PM -
The Safety and Effectiveness of Drug-Induced Sleep Endoscopy in Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis
Sep 9, 2025, 16:22 PM -
Trends in Hospital Treatment of Follicular Lymphoma in Germany
Sep 9, 2025, 16:22 PM -
Real-World Healthcare Resource Utilization and Related Costs Associated With Lung Cancer in the Brazilian Private Market
Sep 9, 2025, 16:22 PM -
US Population-Level Clinical Impact of Lorlatinib Treatment on ALK+ Metastatic Non-Small Cell Lung Cancer Outcomes
Sep 9, 2025, 16:22 PM
